Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies

INTRODUCTION: Drug repositioning is a strategy to identify a new therapeutic indication for molecules that have been approved for other conditions, aiming to speed up the traditional drug development process and reduce its costs. The high prevalence and incidence of coronavirus disease 2019 (COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaz, Elisa Souza, Vassiliades, Sandra Valeria, Giarolla, Jeanine, Polli, Michelle Carneiro, Parise-Filho, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118228/
https://www.ncbi.nlm.nih.gov/pubmed/37081137
http://dx.doi.org/10.1007/s00228-023-03486-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118228/
https://www.ncbi.nlm.nih.gov/pubmed/37081137
http://dx.doi.org/10.1007/s00228-023-03486-4

Ejemplares similares